Junaid Abdulghani M.D.

Junaid Abdulghani, MD, PhD, is an Associate Medical Director in Clinical Development at Novocure, where responsibilities include serving as the global clinical lead for the TRIDENT Study and overseeing various aspects of clinical programs involving Optune® for brain cancer patients. Previous experience includes roles as Medical Director at Jay's Consulting LLC, Associate Director of Medical Affairs at Janssen Inc., and Medical Science Director at Incyte, focusing on oncology and strategic drug development. Early career positions involved significant research at institutions such as Fox Chase Cancer Center and the University of Pennsylvania Health System, where Junaid conducted studies on cancer therapies and cellular mechanisms. Junaid holds a Ph.D. in Biomedical Sciences from Meharry Medical College and an MD from the University of Mumbai.